UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 150

Sortiert nach

Exome sequencing deciphers a germline MET mutation in familial epidermal growth factor receptor‐mutant lung cancer

Cancer science, 2017-06, Vol.108 (6), p.1263-1270

2017

Volltextzugriff (PDF)

Phase II trial of daily S‐1 combined with weekly irinotecan in previously treated patients with advanced or recurrent squamous cell lung cancer: North Japan lung cancer group 1101

Thoracic cancer, 2023-09, Vol.14 (27), p.2804-2810

2023

Volltextzugriff (PDF)

Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice

The Journal of experimental medicine, 2003-03, Vol.197 (5), p.669-674

2003

Volltextzugriff (PDF)

Bilateral Peripheral Infiltrates Refractory to Immunosuppressants were Diagnosed as Autoimmune Pulmonary Alveolar Proteinosis and Improved by Inhalation of Granulocyte/Macrophage-Colony Stimulating Factor

Internal Medicine, 2012, Vol.51(13), pp.1737-1742

2012

Volltextzugriff (PDF)

A phase II study of irinotecan as a third- or fourth-line treatment for advanced non-small cell lung cancer: NJLCG0703

Respiratory investigation, 2013-03, Vol.51 (1), p.28-34

2013

Volltextzugriff (PDF)

Complicated Secondary Pneumonia after Swine-Origin Influenza A Virus Infection in an Immunocompetent Patient

The Tohoku Journal of Experimental Medicine, 2012, Vol.226(2), pp.117-120

2012

Volltextzugriff (PDF)

Successful Treatment of Carcinomatous Meningitis with Gefitinib in a Patient with Lung Adenocarcinoma Harboring a Mutated EGF Receptor Gene

The Tohoku Journal of Experimental Medicine, 2008, Vol.214(4), pp.359-363

2008

Volltextzugriff (PDF)

An effective enrichment strategy for EML4-ALK fusion gene screening in patients with non-small cell lung cancer

Respiratory investigation, 2014-01, Vol.52 (1), p.49-56

2014

Volltextzugriff (PDF)

Vaccination of Dendritic Cells Loaded with Interleukin-12-Secreting Cancer Cells Augments In vivo Antitumor Immunity: Characteristics of Syngeneic and Allogeneic Antigen-Presenting Cell Cancer Hybrid Cells

Clinical cancer research, 2005-01, Vol.11 (1), p.58-66

2005

Volltextzugriff (PDF)

Phase II study of amrubicin combined with carboplatin for refractory relapsed small-cell lung cancer: North Japan Lung Cancer Group Trial 0802

Respiratory investigation, 2014-05, Vol.52 (3), p.190-194

2014

Volltextzugriff (PDF)

Identification and characterization of a novel Rho GTPase activating protein implicated in receptor-mediated endocytosis

FEBS letters, 2004-05, Vol.566 (1), p.294-300

2004

Volltextzugriff (PDF)

Explanation about Saginomiya Viscosity Control System

Marine Engineering, 2017/05/01, Vol.52(3), pp.329-332

2017

Volltextzugriff (PDF)

Prognostic factors for patients with metastatic or recurrent thymic carcinoma receiving palliative-intent chemotherapy

Lung cancer (Amsterdam, Netherlands), 2020-10, Vol.148, p.122-128

2020

Volltextzugriff (PDF)

Randomized Phase II Trial Comparing Carboplatin Plus Weekly Paclitaxel and Docetaxel Alone in Elderly Patients With Advanced Non‐Small Cell Lung Cancer: North Japan Lung Cancer Group Trial 0801

The oncologist (Dayton, Ohio), 2014-04, Vol.19 (4), p.352-353

2014

Volltextzugriff (PDF)

Tissue concentrations of estrogens and aromatase immunolocalization in interstitial pneumonia of human lung

Molecular and cellular endocrinology, 2014-07, Vol.392 (1-2), p.136-143

2014

Volltextzugriff (PDF)

Randomized phase II trial of uracil/tegafur and cisplatin versus vinorelbine and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-small-cell lung cancer: NJLCG 0601

Lung cancer (Amsterdam, Netherlands), 2013-07, Vol.81 (1), p.91-96

2013

Volltextzugriff (PDF)

Abstract 1793: Imatinib treatment for gefitinib-resistant lung cancer harboring epidermal growth factor receptor mutation

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.1793-1793

2012

Volltextzugriff (PDF)

Phase II study of amrubicin (AMR) and carboplatin (CBDCA) for invasive thymoma (IT) and thymic carcinoma (TC): NJLCG0803

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.7530-7530

2013

Volltextzugriff (PDF)

サギノミヤ粘度コントロールシステムについて

マリンエンジニアリング, 2017/05/01, Vol.52(3), pp.329-332

2017

Volltextzugriff (PDF)

Phase II study of amrubicin (AMR) combined with carboplatin (CBDCA) for refractory relapsed small cell lung cancer (SCLC): North Japan Lung Cancer Group 0802

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.7086-7086

2012

Volltextzugriff (PDF)

Randomized phase II trial of carboplatin combined with weekly paclitaxel (CP) and docetaxel alone (D) in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC): NJLCG 0801

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.7565-7565

2012

Volltextzugriff (PDF)

Adenocarcinoma With Epidermal Growth Factor Receptor Gene Mutations in Three Siblings

Journal of thoracic oncology, 2008-03, Vol.3 (3), p.311-313

2008

Volltextzugriff (PDF)

A Case of Small-cell Lung Carcinoma with EGFR Gene Mutation

Haigan, 2011, Vol.51(7), pp.798-802

2011

Volltextzugriff (PDF)

S-1 Combined with Bi-Weekly Docetaxel for Non-Small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy: A Phase II Study of North Japan Lung Cancer Group (NJLCG0701)

Cancer and clinical oncology, 2012-04, Vol.1 (1)

2012

Volltextzugriff (PDF)

Retrospective Analysis of Acquired Resistance During the Treatment with Gefitinib in Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutations

Haigan, 2009, Vol.49(3), pp.257-261

2009

Volltextzugriff (PDF)

1 – 25 von 150

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(138)

Publikationsform

Artikel
(144)
Tagungsberichte
(6)

Sprache

Englisch
(124)
Japanisch
(69)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Exome sequencing deciphers a germline MET mutation in familial epidermal growth factor receptor‐mutant lung cancer

Phase II trial of daily S‐1 combined with weekly irinotecan in previously treated patients with advanced or recurrent squamous cell lung cancer: North Japan lung cancer group 1101

Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice

Bilateral Peripheral Infiltrates Refractory to Immunosuppressants were Diagnosed as Autoimmune Pulmonary Alveolar Proteinosis and Improved by Inhalation of Granulocyte/Macrophage-Colony Stimulating Factor

A phase II study of irinotecan as a third- or fourth-line treatment for advanced non-small cell lung cancer: NJLCG0703

Complicated Secondary Pneumonia after Swine-Origin Influenza A Virus Infection in an Immunocompetent Patient

Successful Treatment of Carcinomatous Meningitis with Gefitinib in a Patient with Lung Adenocarcinoma Harboring a Mutated EGF Receptor Gene

An effective enrichment strategy for EML4-ALK fusion gene screening in patients with non-small cell lung cancer

Vaccination of Dendritic Cells Loaded with Interleukin-12-Secreting Cancer Cells Augments In vivo Antitumor Immunity: Characteristics of Syngeneic and Allogeneic Antigen-Presenting Cell Cancer Hybrid Cells

Phase II study of amrubicin combined with carboplatin for refractory relapsed small-cell lung cancer: North Japan Lung Cancer Group Trial 0802

Identification and characterization of a novel Rho GTPase activating protein implicated in receptor-mediated endocytosis

Explanation about Saginomiya Viscosity Control System

Prognostic factors for patients with metastatic or recurrent thymic carcinoma receiving palliative-intent chemotherapy

Randomized Phase II Trial Comparing Carboplatin Plus Weekly Paclitaxel and Docetaxel Alone in Elderly Patients With Advanced Non‐Small Cell Lung Cancer: North Japan Lung Cancer Group Trial 0801

Tissue concentrations of estrogens and aromatase immunolocalization in interstitial pneumonia of human lung

Randomized phase II trial of uracil/tegafur and cisplatin versus vinorelbine and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-small-cell lung cancer: NJLCG 0601

Abstract 1793: Imatinib treatment for gefitinib-resistant lung cancer harboring epidermal growth factor receptor mutation

Phase II study of amrubicin (AMR) and carboplatin (CBDCA) for invasive thymoma (IT) and thymic carcinoma (TC): NJLCG0803

サギノミヤ粘度コントロールシステムについて

Phase II study of amrubicin (AMR) combined with carboplatin (CBDCA) for refractory relapsed small cell lung cancer (SCLC): North Japan Lung Cancer Group 0802

Randomized phase II trial of carboplatin combined with weekly paclitaxel (CP) and docetaxel alone (D) in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC): NJLCG 0801

Adenocarcinoma With Epidermal Growth Factor Receptor Gene Mutations in Three Siblings

A Case of Small-cell Lung Carcinoma with EGFR Gene Mutation

S-1 Combined with Bi-Weekly Docetaxel for Non-Small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy: A Phase II Study of North Japan Lung Cancer Group (NJLCG0701)

Retrospective Analysis of Acquired Resistance During the Treatment with Gefitinib in Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutations

Suchergebnisse filtern